-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $115

Benzinga·08/04/2026 10:37:54
Listen to the news
Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $113 to $115.